CorrespondenceFrom Cellulite to smooth skin: Is Viagra the new dream cream?

Vaginal and clitoral vasculature are real, measurable, and responsive to nitric oxide signaling.

Medication Type	Interaction Effect	Advice
Nitrates	Severe hypotension (low blood pressure)	Avoid concurrent use
Alpha-blockers	Enhanced blood pressure-lowering effect	Monitor blood pressure
CYP3A4 Inhibitors	Increased plasma levels of sildenafil	Dose adjustment needed

And while desire may be context-dependent, the vascular substrate of arousal is just as pharmacologically valid in women as it is in men.

Conclusion: Healing, Not Just Heat

For many women, the inability to feel arousal is not just about friction or blood flow. It’s about invisibility clinical, relational, and even personal. Not only did the cream improve objective sexual function, it also seemed to change how participants felt about their own bodies. Women reported increased genital awareness, less self-consciousness during intimacy, and greater initiation of sexual activity (journals.lww.com). These outcomes suggest that sildenafil may do more than modulate vasculature, it may influence how women experience themselves during sex.

What is FSAD?

This article discusses how effective arousal treatments for women can be framed in ways that avoid reductionism and reinforce dignity. The 2024 data offer a biochemical mechanism, but they also reopen questions about what arousal means, what sexual healing looks like, and why gender-inclusive models of care are not optional they are overdue. Sexual arousal in women is a physiologic process rooted in blood flow, but shaped by far more than that. Clitoral and vaginal engorgement depend on nitric oxide release, like in the penis, but the architecture is subtler, the timeline more variable, and the interplay with touch and context far more sensitive. Unlike oral formulations, previously trialed with limited success due to inconsistent systemic absorption, this transvaginal approach delivers sildenafil directly to target tissues, with minimal systemic side effects.

Potential side effects

The onset is more localized, and importantly, it circumvents the need for whole-body exposure. In the pilot research, women reported not only increased genital sensation, but a faster transition from desire to readiness to intimacy. Interestingly, the most substantial gains were observed in participants who had reported high sexual distress at baseline. This points toward a neurovascular-emotional feedback loop: when physical readiness improves, psychological readiness may follow and vice versa. But by removing a vascular barrier, it can help clear the path for arousal to occur, especially when the woman is otherwise interested and emotionally open to the experience. Not all cases of FSAD are rooted in inadequate blood flow.

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	200mg	30 + 2 Pills	83.07€ 79.11€	Buy
Viagra Generic	50mg	60 + 4 Pills	83.93€ 79.93€	Buy
Viagra Generic	150mg	270 + 10 Pills	326.61€ 311.06€	Buy
Viagra Generic	25mg	20 Pills	37.74€ 35.94€	Buy
Viagra Original	100mg	12 Pills	72.54€ 69.09€	Buy
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€	Buy
Viagra Generic	50mg	90 + 6 Pills	107.37€ 102.26€	Buy
Viagra Soft Tabs	100mg	180 + 10 Pills	314.95€ 299.95€	Buy
Viagra Generic	50mg	30 + 4 Pills	54.26€ 51.68€	Buy
Viagra Oral Jelly	100mg	63 + 7 Sachets	190.54€ 181.47€	Buy
Viagra Generic	150mg	10 Pills	36.73€ 34.98€	Buy
Viagra Soft Tabs	100mg	60 + 6 Pills	152.94€ 145.66€	Buy

For many women, the arousal barrier lies in trauma, partner dynamics, hormonal shifts, or mood disorders.

HERE IS WHAT SHE SAYS...

The experience of arousal is not only physical. It is psychological, symbolic, and deeply somatic. It is not just a state of lubrication best viagra for men or swelling but a sense of being alive in one’s body, responsive, attuned, and, perhaps most importantly, deserving pleasure. For many women with FSAD, that sense of attunement is precisely what has gone missing. The pilot trial of topical sildenafil cream reported improvements not only in genital response, but also in body confidence, particularly in participants who began the study with high levels of sexual dissatisfaction.

Key Takeaways

These findings echo earlier observations that female arousal disorders often coexist with distorted body image, trauma histories, or relational fatigue. When arousal becomes unreliable or absent, women frequently internalize it as failure not just of the body, but of femininity itself. This is where pharmacology intersects with psychology in a way that demands careful framing. A cream cannot rewrite personal history or undo self-doubt. However, it can offer something quieter: a re-entry point, a moment where the body responds and the mind, perhaps surprised, leans in rather than away.

How it Helps You Do It

Some women describe it not as “getting aroused” but as “remembering how to feel.” Such effects should not be overstated, but neither should they be dismissed as placebo. When sensation returns in a body long tuned out, it can catalyze confidence and reorient a woman’s relationship to touch, trust, and intimacy. In this sense, topical sildenafil is not a solution, but a facilitator, a medication that creates conditions where safety and sensation might meet. And in a medical culture that still too often divides the genital from the psychological, that integration is already progress. The field of sexual medicine has historically been shaped by male physiology. In such cases, a topical cream may not resolve the root cause, and framing it as a universal fix risks reinforcing a reductive, body-only model of female sexuality.

Area	Focus	Potential Benefits
Enhanced formulation	Longer-lasting effects	Fewer applications needed
Combination products	Combining with other PDE5 inhibitors	Broader therapeutic effects
Novel delivery systems	Nanoemulsions, patches	Improved absorption, convenience
Safety profiling	Long-term studies	Better understanding of side effects

The more progressive vision is one of integration: pharmacological tools used with humility

Section snippets

For now, the product is available as a compounded topical through Section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA), meaning it is produced at an FDA-registered outsourcing facility. The cream underwent toxicology testing; a randomized, placebo-controlled study; and was manufactured under cGMP requirements. “What we’re hoping we’re doing is a correction to the system,” Johnson says. It’s not niche for half the population. I feel like these are billion-dollar opportunities hiding in plain sight.” Explore your whole life health with expert interviews, stories from real people, health innovations, research, products, and fun recommendations.

Sildenafil in O-mazing

Explore your whole life health with expert interviews, stories from real people, health innovations, research, products, and fun recommendations. Sexual dysfunction in women has long hovered at the edge of clinical conversations, recognized but under-investigated, named but rarely prioritized. While male sexual health became a pharmaceutical frontier with the approval of Viagra in 1998, female arousal disorders remained in a therapeutic vacuum. Until recently, much of what passed for treatment was indirect: hormone replacement, psychotherapy, lubricants. What was viagra sildenafil price missing was not only efficacy, but attention.

Increased sexual response in a cream

In 2024, a multicenter pilot trial of topical sildenafil 3.6% cream in women with Female Sexual Arousal Disorder (FSAD) (PMC) reported statistically significant improvements in subjective arousal, genital engorgement, and—perhaps most strikingly, body-image confidence. The findings were most pronounced in women who began the study with high levels of sexual distress. It was measurable, meaningful, and deeply suggestive. This is of great importance, because FSAD is more than a vascular issue. It is where biology and psychology meet: where impaired genital responsiveness collides with internalized shame, fear of touch, or simply the loss of ease within one’s own skin. and clarity, situated within a broader ecosystem of relational, psychological, and cultural factors.

Interested, but not quite ready?

Johnson hopes this launch marks a shift toward closing the gender desire gap. “Men were very loud about the fact that it was so critical to their sexual function and sexual activity to be able to have an erection. With women, it has been viewed as more complicated … but it’s not,” says Johnson. “It’s really not that much more complicated. There’s desire [and] there’s arousal, just like in men.” Johnson, who has worked in women’s health innovation for over two decades, hopes this product not only serves women’s sexual health but also normalizes it as an integral pillar of their whole health.

Can topical sildenafil improve sex?

In the meantime, DARE to PLAY joins a sparse field of prescription arousal products for women. Sprout Pharmaceuticals’ Addyi, a pill to treat hypoactive sexual desire disorder in premenopausal women, faced an uphill battle before receiving FDA approval in 2015. As Dr. Sadaf Lodhi, a sex counselor and board-certified OB-GYN, told Flow Space, women have long felt obligated to normalize low libido and painful sex. Ten years ago, no one was talking about libido as much.

Let's do it.

[Women] don’t need to settle for sex being painful or a decreased libido if it’s bothering them,” she says. “To want sex is to have sex worth wanting. I always say to my patients, ‘if you’re not experiencing pleasure with intimacy, then you’re not going to want it.’” Johnson says that successfully creating the formulation, ensuring it could work in 10 minutes, was integral to getting the cream to market to serve women’s needs. “Decades of underfunding and underdevelopment have also led many women to deprioritize their sexual health or, worse, turn to risky, unregulated treatments that, more and more, are being advertised as safe and effective,” says Johnson. “I think we’ll start to see women put more pressure on companies to deliver real, science-backed solutions.” While Daré Bioscience’s cream is not currently FDA-approved, Johnson has her sights on approval in the future. Topical sildenafil doesn’t promise to ignite desire or rewrite intimacy. But it may offer a starting point, one that is tangible, accessible, and, most importantly,

• Viagra cream can provide localized effects on erectile tissue.
• It might offer quicker results than oral medications.
• Some products claim longer-lasting erections with topical use.
• Topical application reduces the risk of some systemic adverse effects.
• Efficacy reports are anecdotal; clinical trials are limited.
• Proper application involves a gentle massage into the skin.
• Dosage instructions are essential for safety and effectiveness.
• Not recommended for use by women or children.
• Some products may contain unverified or unsafe ingredients.
• Always verify the legitimacy of the product before purchase.

based on the premise that women’s sexual discomfort is worth treating at the biological level.

• Viagra cream may be marketed with claims of increased stamina.
• It can be part of a broader sexual wellness routine.
• Some products include herbal or natural extracts.
• Expect varying degrees of success based on individual factors.
• Use in combination with foreplay can enhance results.
• It is not a substitute for medical treatment of ED.
• Some formulations require refrigeration for storage.
• Discontinue if adverse reactions happen promptly.
• The cream should be used responsibly and ethically.
• Do not rely solely on topical products for ED issues.

It’s philosophical, as it asks us to stop filtering female arousal through the lens of comparison,

Introduction: Sexual Health, Gender, and the Visibility Gap

Erectile dysfunction became a biomedical entity with clear endpoints and was met with pharmacological solutions. In contrast, female sexual arousal disorder (FSAD) has been long viewed as diffuse, emotional, elusive, difficult to measure, harder to treat, and, by implication, less deserving of intervention. Women reporting arousal difficulties are often met with suggestions to “reduce stress,” “improve foreplay,” or “try therapy.” These are not irrelevant strategies, but they stand in stark contrast to the pharmacological directness offered to men. The implication is subtle but persistent: men deserve molecular solutions; women require patience. Topical sildenafil cream represents a step toward correcting this imbalance, not because it mirrors the male experience, but because it honors the physiological reality of female genital response. and to instead build a framework that reflects the diversity of how women experience and reclaim pleasure.

Ingredient	Concentration (%)	Function	Source
Sildenafil Citrate	2.5	Main active ingredient	Pharmaceutical lab
Emulsifiers	1.5	Improve texture	Chemical suppliers
Preservatives	0.2	Extend shelf life	Chemical suppliers
Moisturizers	3.0	Skin hydration	Cosmetic manufacturers

If you’re reading this with curiosity—perhaps a hint of hesitation—you’re not alone.

• Viagra cream offers potential for personalized dosing.
• It might be used in combinations with other topical therapies.
• Some formulations include numbing agents for comfort.
• The market is driven by demand for non-invasive ED solutions.
• Long-term safety data is currently lacking.
• Its use is often driven by convenience and privacy.
• The cream's active ingredient is usually sildenafil, similar to tablets.
• Some products claim to enhance libido beyond ED treatment.
• Use of Viagra cream does not replace professional diagnosis.
• Monitoring by healthcare providers is advised when used regularly.

Copyright

Unless otherwise stated, the "Person responsible for the content" holds all text rights. The image rights belong either to the "Person responsible for the content" or to Webbaumeister or their partners.

Availability

The provider of this website and the Web agency Webbaumeister (Basel, Winterthur), their partner for professional web design and search engine optimization, do everything possible to ensure maximum availability of this website.